These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 20422926)

  • 1. [Diversification of influenza viruses].
    Marian CV; Mihăescu G
    Bacteriol Virusol Parazitol Epidemiol; 2009; 54(2):117-23. PubMed ID: 20422926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular epidemiology of influenza viruses: a lesson from a highly epidemic season.
    D'Agaro P; Rossi T; Burgnich P; Molin GD; Coppola N; Rocco G; Campello C
    J Clin Pathol; 2008 Mar; 61(3):355-60. PubMed ID: 17630401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Public health. Rethinking influenza.
    Rappuoli R; Del Giudice G; Nabel GJ; Osterhaus AD; Robinson R; Salisbury D; Stöhr K; Treanor JJ
    Science; 2009 Oct; 326(5949):50. PubMed ID: 19797644
    [No Abstract]   [Full Text] [Related]  

  • 4. Influenza vaccine: the challenge of antigenic drift.
    Carrat F; Flahault A
    Vaccine; 2007 Sep; 25(39-40):6852-62. PubMed ID: 17719149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influenza season 2007/'08 in the Netherlands: antigenic variation, oseltamivir resistance and vaccine composition for the 2008/'09 season].
    Rimmelzwaan GF; de Jong JC; Donker GA; Meijer A; Fouchier RA; Osterhaus AD
    Ned Tijdschr Geneeskd; 2008 Sep; 152(39):2138-44. PubMed ID: 18856032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double dose. Two flu vaccines on tap this season.
    Ford J
    Adv Nurse Pract; 2009 Oct; 17(10):41-2. PubMed ID: 20000163
    [No Abstract]   [Full Text] [Related]  

  • 7. Influenza virus: a master of metamorphosis.
    De Jong JC; Rimmelzwaan GF; Fouchier RA; Osterhaus AD
    J Infect; 2000 May; 40(3):218-28. PubMed ID: 10908015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza vaccine: an effective preventive vaccine for developing countries.
    Verma R; Khanna P; Chawla S
    Hum Vaccin Immunother; 2012 May; 8(5):675-8. PubMed ID: 22634439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation.
    Baguelin M; Hoek AJ; Jit M; Flasche S; White PJ; Edmunds WJ
    Vaccine; 2010 Mar; 28(12):2370-84. PubMed ID: 20096762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Swine influenza virus: zoonotic potential and vaccination strategies for the control of avian and swine influenzas.
    Thacker E; Janke B
    J Infect Dis; 2008 Feb; 197 Suppl 1():S19-24. PubMed ID: 18269323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Swine flu vaccines: reaching the finish line.
    Davies J
    Cell; 2009 Oct; 139(3):449-51. PubMed ID: 19879829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
    Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
    Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Swine flu outbreak. China first to vaccinate against novel H1N1 virus.
    Stone R
    Science; 2009 Sep; 325(5947):1482-3. PubMed ID: 19762610
    [No Abstract]   [Full Text] [Related]  

  • 14. Swine flu outbreak. New details on virus's promiscuous past.
    Cohen J
    Science; 2009 May; 324(5931):1127. PubMed ID: 19478151
    [No Abstract]   [Full Text] [Related]  

  • 15. Influenza a (H1N1) outbreak and challenges for pharmacotherapy.
    Chawla R; Sharma RK; Bhardwaj JR
    Indian J Physiol Pharmacol; 2009; 53(2):113-26. PubMed ID: 20112815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal models for the preclinical evaluation of candidate influenza vaccines.
    Bodewes R; Rimmelzwaan GF; Osterhaus AD
    Expert Rev Vaccines; 2010 Jan; 9(1):59-72. PubMed ID: 20021306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution.
    Ghedin E; Sengamalay NA; Shumway M; Zaborsky J; Feldblyum T; Subbu V; Spiro DJ; Sitz J; Koo H; Bolotov P; Dernovoy D; Tatusova T; Bao Y; St George K; Taylor J; Lipman DJ; Fraser CM; Taubenberger JK; Salzberg SL
    Nature; 2005 Oct; 437(7062):1162-6. PubMed ID: 16208317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influenza season 1998/99; composition of vaccine for 1999/2000].
    Rimmelzwaan GF; de Jong JC; Bartelds AI; Dorigo-Zetsma JW; Fouchier RA; Osterhaus AD
    Ned Tijdschr Geneeskd; 1999 Oct; 143(40):2015-8. PubMed ID: 10535060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A CTL-based liposomal vaccine capable of inducing protection against heterosubtypic influenza viruses in HLA-A*0201 transgenic mice.
    Matsui M; Kohyama S; Suda T; Yokoyama S; Mori M; Kobayashi A; Taneichi M; Uchida T
    Biochem Biophys Res Commun; 2010 Jan; 391(3):1494-9. PubMed ID: 20060099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The influenza season 2004/'05 in the Netherlands with the largest epidemic of the last 5 years caused by the virus variant A/California and the composition of the vaccine for the season 2005/'06].
    de Jong JC; Rimmelzwaan GF; Bartelds AI; Meijer A; Fouchier RA; Osterhaus AD
    Ned Tijdschr Geneeskd; 2005 Oct; 149(42):2355-61. PubMed ID: 16261717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.